Return to homepagePandemic Pact

SALFastCov: Rapid saliva detection of SARS-CoV-2 responsible for Covid19.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    ANR

  • Principal Investigator

    Clémence Richetta

  • Research Location

    France

  • Lead Research Institution

    ENS Paris-Saclay

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The SALFastCov project, coordinated by Clémence Richetta (UMR 8113 - Laboratory of Applied Biology and Pharmacology (LBPA) - ENS Paris-Saclay), aims to adapt the test for the rapid, sensitive and reliable detection of the viral genome in nasopharyngeal samples, which the The team has previously developed the detection of viruses in saliva samples. Saliva sampling is easier to perform and less invasive, however the correlation between the viral load present in the nasopharyngeal level and that present in saliva is not well known. The project will focus on determining whether a correlation exists between the viral load present in the nasopharynx and that present in the saliva of symptomatic and asymptomatic patients.